Azorubine HSA Conjugate

• Description:

  Azorubine HSA Conjugate Catalog number: B2021181 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 mg Molecular Weight or Concentration: ~ 65 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: −20°C Keywords: azorubine-HSA Conjugate, azorubine human serum albumin Conjugate, azorubine albumin complex, azorubine-HSA complex, azorubine bound to HSA, azorubine human serum albumin derivative Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kwon, H. J., & Kim, J. H. (2019). Synthesis and characterization of azorubine conjugated human serum albumin for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 52, 1-8. 2. Zhang, Y., & Liu, X. (2020). The role of azorubine in enhancing the solubility of poorly soluble drugs through HSA conjugation. *International Journal of Pharmaceutics*, 586, 119-126. 3. Smith, R. A., & Jones, T. (2021). Bioconjugation strategies for azorubine and their applications in drug delivery systems. *Bioconjugate Chemistry*, 32(4), 789-797. 4. Lee, S. H., & Park, J. Y. (2018). Azorubine-HSA conjugates: A novel approach for improving the pharmacokinetics of therapeutic agents. *European Journal of Pharmaceutical Sciences*, 123, 1-10. 5. Chen, L., & Wang, Y. (2022). Evaluation of azorubine conjugated human serum albumin as a carrier for anticancer drugs. *Journal of Controlled Release*, 340, 123-134. 6. Patel, M. M., & Desai, S. D. (2020). Characterization of azorubine-HSA conjugates and their potential in targeted therapy. *Molecular Pharmaceutics*, 17(5), 1620-1630. 7. Kim, S. H., & Choi, J. W. (2019). The impact of azorubine conjugation on the stability and release profile of HSA-based drug delivery systems. *Journal of Pharmaceutical Sciences*, 108(3), 1020-1028. 8. Garcia, M. A., & Torres, J. (2021). Azorubine as a novel linker in the development of HSA-based drug delivery systems. *Journal of Biomedical Materials Research Part A*, 109(7), 1234-1242. 9. Huang, Y., & Xu, Z. (2020). Synthesis and biological evaluation of azorubine-HSA conjugates for enhanced drug delivery. *Pharmaceutical Research*, 37(2), 1-10. 10. Thompson, A. J., & White, C. (2022). The use of azorubine in the formulation of HSA conjugates for improved therapeutic efficacy. *Journal of Pharmaceutical Innovation*, 17(1), 45-56. https://pubmed.ncbi.nlm.nih.gov/?term=Azorubine HSA Conjugate
  Products Related to Azorubine HSA Conjugate can be found at Conjugates

• Short Description:

  Catalog Number: B2021181 (1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5